A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors by Sun, Weijing, Stevenson, James P., Gallagher, Maryann, Giantonio, Bruce, Algazy, Kenneth, Haller, Dan, Vaughn, David, Raskay, Barbara J., O'Dwyer, Peter J.

Get full text

Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT by LARSON, Garry P, YAN DING, SLATER, Jerry, NEUBERG, Donna, DALY, Mary B, ANGEL, Irene, BENSON, Al B, SMITH, Kimberly, KIRKWOOD, John M, O'DWYER, Peter J, RASKAY, Barbara, SUTPHEN, Rebecca, CHENG, Li S-C, DREW, Rosalind, STEWART, James A, WERNDLI, Jae, JOHNSON, David, RUCKDESCHEL, John C, ELSTON, Robert C, KRONTIRIS, Theodore G, LUNDBERG, Cathryn, GAGALANG, Virgil, RIVAS, Guillermo, GELLER, Louis, WEITZEL, Jeffrey, MACDONALD, Deborah, ARCHAMBEAU, John

Get full text

Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas by SCHER, R. M, KOSIEROWSKI, R, O'DWYER, P. J, LUSCH, C, ALEXANDER, R, FOX, S, REDEI, I, GREEN, F, RASKAY, B, AMFOH, K, ENGSTROM, P. F

Get full text

Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas by Scher, R M, Kosierowski, R, Lusch, C, Alexander, R, Fox, S, Redei, I, Green, F, Raskay, B, Amfoh, K, Engstrom, P F, O'Dwyer, P J

Get full text